Cargando…
Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
In the past two decades, the emergence of coronavirus diseases has been dire distress on both continental and global fronts and has resulted in the search for potent treatment strategies. One crucial challenge in this search is the recurrent mutations in the causative virus spike protein, which lead...
Autores principales: | Obeng, Eugene M., Dzuvor, Christian K.O., Danquah, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608585/ https://www.ncbi.nlm.nih.gov/pubmed/34840592 http://dx.doi.org/10.1016/j.nantod.2021.101350 |
Ejemplares similares
-
Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
por: Verkhivker, Gennady
Publicado: (2022) -
Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era
por: Dzuvor, Christian K. O., et al.
Publicado: (2022) -
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021) -
Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
por: Gaspar, Emanuelle Baldo, et al.
Publicado: (2021) -
Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development
por: Obeng, Eugene M., et al.
Publicado: (2022)